SYFB Polyclonal Antibody, 20ul DNA Fragments Cdks are considered potential targets

Cdks are considered potential targets for anti-cancer therapy due to their involvement with cell cycle regulation

and is an important therapeutic target for the treatment of hypomotility disorders

and alterations in the expression of PAX5 are thought to contribute to neoplastic transformation

This protein is a ligand for the seven transmembrane receptor frizzled-5 and the tyrosine kinase orphan receptor 2

Alterations in this region have been associated with the Beckwith-Wiedemann syndrome

SYFB Polyclonal Antibody, 20ul DNA Fragments Cdks are considered potential targetsThis gene encodes a highly conserved enzyme that belongs to the aminoacyl tRNA synthetase class IIc subfamily. This enzyme comprises the regulatory beta subunits that form a tetramer with two catalytic alpha subunits. In the presence of ATP, this tetramer is responsible for attaching L phenylalanine to the terminal adenosine of the appropriate tRNA. A pseudogene located on chromosome 10 has been identified. Alternative splicing results in multiple